Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89164143 | 8916414 | 3 | F | 20100725 | 20160815 | 20121120 | 20160824 | EXP | GB-PFIZER INC-2012286509 | PFIZER | 16.00 | YR | F | Y | 66.00000 | KG | 20160824 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89164143 | 8916414 | 1 | PS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 60 MG, CYCLIC, TWICE PER CYCLE | U | 50467 | 60 | MG | |||||||
| 89164143 | 8916414 | 2 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG, CYCLIC, ONCE PER CYCLE | U | UNK | 0 | 2 | MG | ||||||
| 89164143 | 8916414 | 3 | SS | DACTINOMYCIN | DACTINOMYCIN | 1 | Intravenous (not otherwise specified) | 2 MG, CYCLIC (2 MG, CYCLIC, ONCE PER CYCLE) | U | 0 | 2 | MG | |||||||
| 89164143 | 8916414 | 4 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 6 G, CYCLIC, TWICE PER CYCLE | U | 0 | 6 | G | |||||||
| 89164143 | 8916414 | 5 | C | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | 6 MG, UNK | 0 | 6 | MG | |||||||||
| 89164143 | 8916414 | 6 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | 150 MG, UNK | 0 | 150 | MG | |||||||||
| 89164143 | 8916414 | 7 | C | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | 50 UG, EVERY 3 DAYS | 1800 | UG | 0 | 50 | UG | TRANSDERMAL PATCH | ||||||
| 89164143 | 8916414 | 8 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 24 MG, UNK | 0 | 24 | MG | |||||||||
| 89164143 | 8916414 | 9 | C | MAGNESIUM ASPARTATE | MAGNESIUM ASPARTATE | 1 | 20 MMOL, UNK | 0 | 20 | MMOL | |||||||||
| 89164143 | 8916414 | 10 | C | PHOSPHATE-SANDOZ | SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | 1 | UNK | 0 | |||||||||||
| 89164143 | 8916414 | 11 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 89164143 | 8916414 | 12 | C | SEVREDOL | MORPHINE | 1 | 20 MG, EVERY HOURS, AS NEEDED | 0 | 20 | MG | |||||||||
| 89164143 | 8916414 | 13 | C | GRANISETRON | GRANISETRON | 1 | 1 MG, UNK | 0 | 1 | MG | |||||||||
| 89164143 | 8916414 | 14 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | 2.5 G, UNK | 0 | 2.5 | G | |||||||||
| 89164143 | 8916414 | 15 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | 18 G, UNK | 0 | 18 | G | |||||||||
| 89164143 | 8916414 | 16 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 960 MG, UNK | 0 | 960 | MG | |||||||||
| 89164143 | 8916414 | 17 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 15 MG, UNK | 0 | 15 | MG | |||||||||
| 89164143 | 8916414 | 18 | C | ONDANSETRON | ONDANSETRON | 1 | 24 MG, UNK | 0 | 24 | MG | |||||||||
| 89164143 | 8916414 | 19 | C | LACTULOSE. | LACTULOSE | 1 | 15 MG, UNK | 0 | 15 | MG | |||||||||
| 89164143 | 8916414 | 20 | C | NABILONE | NABILONE | 1 | 3 MG, UNK | 0 | 3 | MG | |||||||||
| 89164143 | 8916414 | 21 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 89164143 | 8916414 | 22 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 89164143 | 8916414 | 23 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 4 G, UNK | 0 | 4 | G | |||||||||
| 89164143 | 8916414 | 24 | C | PHENYLEPHRINE HYDROCHLORIDE/TROPICAMIDE | 2 | UNK | 0 | ||||||||||||
| 89164143 | 8916414 | 25 | C | GABAPENTIN. | GABAPENTIN | 1 | 1500 MG, UNK | 0 | 1500 | MG | |||||||||
| 89164143 | 8916414 | 26 | C | SANDO K | 2 | 4 DF, UNK | 0 | 4 | DF | ||||||||||
| 89164143 | 8916414 | 27 | C | TROPICAMIDE. | TROPICAMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89164143 | 8916414 | 1 | Rhabdomyosarcoma |
| 89164143 | 8916414 | 2 | Rhabdomyosarcoma |
| 89164143 | 8916414 | 3 | Rhabdomyosarcoma |
| 89164143 | 8916414 | 4 | Rhabdomyosarcoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 89164143 | 8916414 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89164143 | 8916414 | Febrile neutropenia | |
| 89164143 | 8916414 | Presyncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 89164143 | 8916414 | 1 | 20100618 | 0 | ||
| 89164143 | 8916414 | 2 | 20100618 | 0 | ||
| 89164143 | 8916414 | 3 | 20100618 | 0 | ||
| 89164143 | 8916414 | 4 | 20100618 | 0 | ||
| 89164143 | 8916414 | 5 | 20100924 | 20100929 | 0 | |
| 89164143 | 8916414 | 6 | 20100924 | 0 | ||
| 89164143 | 8916414 | 7 | 20100713 | 0 | ||
| 89164143 | 8916414 | 8 | 20100713 | 20100930 | 0 | |
| 89164143 | 8916414 | 9 | 20100612 | 0 | ||
| 89164143 | 8916414 | 10 | 20100717 | 0 | ||
| 89164143 | 8916414 | 11 | 20101015 | 0 | ||
| 89164143 | 8916414 | 12 | 20100617 | 0 | ||
| 89164143 | 8916414 | 13 | 20100620 | 0 | ||
| 89164143 | 8916414 | 14 | 20100716 | 0 | ||
| 89164143 | 8916414 | 15 | 20100722 | 0 | ||
| 89164143 | 8916414 | 16 | 20100621 | 0 | ||
| 89164143 | 8916414 | 17 | 20100621 | 0 | ||
| 89164143 | 8916414 | 18 | 20100722 | 0 | ||
| 89164143 | 8916414 | 19 | 20100725 | 0 | ||
| 89164143 | 8916414 | 20 | 20100714 | 0 | ||
| 89164143 | 8916414 | 21 | 20100713 | 0 | ||
| 89164143 | 8916414 | 22 | 20100614 | 0 | ||
| 89164143 | 8916414 | 23 | 20100909 | 0 | ||
| 89164143 | 8916414 | 24 | 20100717 | 0 | ||
| 89164143 | 8916414 | 25 | 20100909 | 0 | ||
| 89164143 | 8916414 | 26 | 20100724 | 0 |